Clinical Trial Update: A Study to Evaluate the Mucosal Intestinal Immunity to Poliovirus Type-2 of nOPV2 at Birth Dose in Healthy IPV Vaccinated Infants [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating mucosal immunity to poliovirus type-2 after birth-dose nOPV2 in healthy IPV-vaccinated infants; the study status is not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• nOPV2 (novel oral polio vaccine type 2)

Snippet

Sponsor: Fidec Corporation | Conditions: Poliomyelitis | Phase 3 | Status: NOT_YET_RECRUITING